Search

Your search keyword '"Surinder K. Batra"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Surinder K. Batra" Remove constraint Author: "Surinder K. Batra" Topic animals Remove constraint Topic: animals
217 results on '"Surinder K. Batra"'

Search Results

1. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma

2. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications

3. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion

4. MASTL regulates EGFR signaling to impact pancreatic cancer progression

5. ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation

6. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression

7. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness

8. The Current Landscape of Antibody-based Therapies in Solid Malignancies

9. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer

10. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis

11. CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma

12. Neutrophil Gelatinase–Associated Lipocalin Protects Acinar Cells From Cerulein-Induced Damage During Acute Pancreatitis

13. Polyanhydride nanoparticles stabilize pancreatic cancer antigen <scp>MUC4β</scp>

14. Unraveling mucin domains in cancer and metastasis: when protectors become predators

15. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling

16. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer

17. MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB)

18. Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer

19. Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma

20. Malondialdehyde-Acetaldehyde Extracellular Matrix Protein Adducts Attenuate Unfolded Protein Response During Alcohol and Smoking–Induced Pancreatitis

21. Mucins, gut microbiota, and postbiotics role in colorectal cancer

22. MUC5AC serves as the nexus for β-catenin/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance

23. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities

24. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models

25. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis

26. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer

27. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention

28. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer

29. DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis

30. Response to correspondence on 'Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation'

31. RNA-based therapies: A cog in the wheel of lung cancer defense

32. Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring

33. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis

34. Mucin 5AC–Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity

35. PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions

36. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model

37. Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis

38. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma

39. Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling

40. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

41. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy

42. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis

43. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting

44. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice

45. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis

46. MUC16 as a novel target for cancer therapy

47. Emerging therapeutic potential of graviola and its constituents in cancers

48. Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view

49. Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism

50. Modeling pancreatic cancer in mice for experimental therapeutics

Catalog

Books, media, physical & digital resources